AU1388501A - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
AU1388501A
AU1388501A AU13885/01A AU1388501A AU1388501A AU 1388501 A AU1388501 A AU 1388501A AU 13885/01 A AU13885/01 A AU 13885/01A AU 1388501 A AU1388501 A AU 1388501A AU 1388501 A AU1388501 A AU 1388501A
Authority
AU
Australia
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13885/01A
Inventor
Karrar A. Khan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Publication of AU1388501A publication Critical patent/AU1388501A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
AU13885/01A 1999-11-06 2000-10-27 Pharmaceutical formulation Abandoned AU1388501A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9926251.1A GB9926251D0 (en) 1999-11-06 1999-11-06 Pharmaceutical formulation
GB9926251 1999-11-06
PCT/EP2000/010582 WO2001034140A1 (en) 1999-11-06 2000-10-27 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
AU1388501A true AU1388501A (en) 2001-06-06

Family

ID=10864032

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13885/01A Abandoned AU1388501A (en) 1999-11-06 2000-10-27 Pharmaceutical formulation

Country Status (7)

Country Link
EP (1) EP1274412A1 (en)
JP (1) JP2003519622A (en)
AR (1) AR029406A1 (en)
AU (1) AU1388501A (en)
CA (1) CA2390128A1 (en)
GB (1) GB9926251D0 (en)
WO (1) WO2001034140A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096202A1 (en) * 2003-04-28 2004-11-11 Cipla Limited Pharmaceutical formulation comprising anti-obesity agent and acidulant
KR100781882B1 (en) * 2005-07-12 2007-12-05 주식회사유한양행 A pharmaceutical composition containing sibutramine
KR100857724B1 (en) 2006-06-30 2008-09-10 한올제약주식회사 The solid dispersion of an oral medication for improved the solubility and dissolution rate of poorly water soluble sibutramine
KR100886542B1 (en) 2007-02-16 2009-03-02 주식회사 드림파마 A composition for solubilizing sibutramine and a method for preparing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
GB9926251D0 (en) 2000-01-12
AR029406A1 (en) 2003-06-25
WO2001034140A1 (en) 2001-05-17
CA2390128A1 (en) 2001-05-17
EP1274412A1 (en) 2003-01-15
JP2003519622A (en) 2003-06-24

Similar Documents

Publication Publication Date Title
AU1071301A (en) Pharmaceutical compounds
PL351526A1 (en) Pharmaceutical formulation comprising amoxycillin
AU5259100A (en) Medicament
AU3192700A (en) Medicinal compositions
AU2002257582A1 (en) Pharmaceutical formulation
AU3556400A (en) Pharmaceutical compositions
AU4328800A (en) Pharmaceutical formulation
AU2005300A (en) Medicinal compositions
AU1887401A (en) Medicinal composition
AU6715600A (en) Pharmaceutical formulations
AU4304400A (en) Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives
AU5460800A (en) Pharmaceutical transdermal compositions
AU6460400A (en) Pharmaceutical compositions
AU4977300A (en) Pharmaceutical formulations
AU1385801A (en) Pharmaceutical formulations
AU6460200A (en) Pharmaceutical compositions
AU5722900A (en) Pharmaceutical compounds
AU3839900A (en) Pharmaceutical formulation
AU6460100A (en) Pharmaceutical compositions
AU6460300A (en) Pharmaceutical compositions
AU4543500A (en) Pharmaceutical compositions and uses
AU1388501A (en) Pharmaceutical formulation
AU4914400A (en) Novel pharmaceutical composition
AU5182099A (en) Pharmaceutical formulation
AU3989100A (en) Pharmaceutical gel formulation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase